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Abstract: 
MicroRNAs have been implicated for the regulation of gene expression. These miRNA are a class of single stranded non coding RNAs, formed from 
endogenous transcripts and measure typically about 19-25 nucleotides in length. They are important regulators of the various biological and metabolic 
functions taking place in humans. Many miRNAs show tissue specific expression.  Human heart is a complex organ which during various diseased and 
developed conditions shows differential expression of miRNA. Here, we overview the recent findings on miRNA in cardiac diseases and report the 
presence of  high AU content in differentially expressed miRNA in developed and diseased condition of heart as compared to all the miRNA present in 
the human. A total of 905 human miRNA sequences taken from miRBase were computationally analyzed. Trend analysis was performed to study the 
influence of positional frequency of the nucleotides. This study will help us in understanding the significance of AU rich elements in miRNA during the 
development of cardiac diseases. 
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Background: 
Gene expression in mammalian system is influenced by various factors. 
One such factor is a class of small non coding RNA sequences- micro 
RNA (miRNA), small interfering RNA (siRNA), transfer RNA (tRNA), 
ribosomal RNA (rRNA) and many more. Some of these non-coding RNAs 
are involved in silencing the gene expression by the process of RNA 
interference. RNA interference is an effective mechanism for sequence 
specific regulation of gene expression [1]. 
 
MicroRNAs are small, non-coding regulatory RNA of around 22bp length 
that are the key regulators of gene expression. They bind to specific sites in 
the 3’UTR region of the transcribed genes and inhibit protein expression 
either by mRNA degradation or by inhibition of translational processes, by 
cleavage or by repressing translation by complementary binding [2].  They 
play significant roles in various important biological processes, including 
diseases, developmental processes, signal transduction, cell maintenance 
and differentiation [3, 4]. MiRNAs are evolutionarily ancient component 
of genetic regulation and are well conserved in eukaryotic organisms. Till 
date, more than 900 human miRNAs have been reported, and estimated to 
regulate more than one third of cellular messenger RNAs. Various 
experiments have been done which relate dysregulated expression of 
miRNAs to a variety of diseases, such as neurodegenerative diseases, 
cancer, cardiovascular diseases and viral infections [5, 6]. 
 
Many miRNAs are enriched in a tissue-specific manner [7], for example 
miR-1, miR-16, miR-27b, miR-30d, miR-126, miR-133, miR-143, and the 
let-7 family are abundantly expressed in adult cardiac tissue. The heart 
may also contain many other non-cardiomyocyte cell types, such as 
endothelial cells, smooth muscle cells, fibroblasts, and immune cells, 
which have distinct miRNA expression profiles. During cardiac diseases 
and developemental changes, miRNA pattern profiles show differential 
pattern. MiRNAs otherwise silenced in adult cardiac cells, tend to get re-
expressed in several cardiac diseases [8, 9]. Chronic exposure to stress 
signals eventually leads to impaired function which finally results in 
cardiac failure. The involvement of miRNAs in this pathological process 
has been recently found [8, 10]. 
 
MicroRNAs control gene expression by inhibiting the translation and 
destabilizing the mRNAs. Emerging evidence suggests a direct link 
between miRNA and diseases. The mammalian cell sequences with a high 
AU content have been shown to cause mRNA instability [13].  
  
Methodology: 
The microRNA dataset comprises experimentally validated sequences 
derived from published data. The information was classified with respect 
to the association with their expression in heart diseases as reported in the 
literature. The sequence data was primarily derived from miRBase 
(http://www.mirbase.org/) for humans. 
 
miRBase is a centralized online repository for nomenclature, sequence 
data, annotation and target prediction of all published miRNA. It provides 
a user-friendly interface for miRNA. It provides a range of data to facilitate 
studies of miRNA genomics. All miRNAs are mapped to their genomic 
coordinates. Clusters of miRNA sequences in the genome are highlighted, 
and can be defined and retrieved with any inter-miRNA distance. 
Sequences from the database as mature sequences in unaligned FASTA 
format were retrieved [11]. 
 
Sequence composition namely A%, U%, G%, C%, A+U% & G+C% was 
estimated manually and computationally using BioEdit software 
(http://www.mbio.ncsu.edu/bioedit/bioedit.html), inhouse perl scripts as 
well as DNA SCANNER software 
(http://nldsps.jnu.ac.in/bioit/ccbb/dnascanner_help.html) [12]. 
 
Disparity in sequence length was eliminated through alignment and 
positional frequency for the four nucleotides was estimated using script 
MSA.pl for both all (control) and the upregulated (test) sequences. The 
relative frequency (RF) was computed by dividing the positional frequency 
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(PF) by the total number of sequences and further estimation was done by 
Trend Analysis [13]. 
 
RF was calculated for each position in aligned sequences and was plotted 
in MS-Excel software (Figure 1). The positional variation was estimated 
using Trend Analysis for both all (control) and upregulated (test) dataset. 
The function COUNTIF was used to count the number of nucleotide at 
each position and hence the positional frequencies were known. At each 
position of the sequence the relative frequency of each nucleotide was 
calculated by dividing the positional frequencies by the total number of 
sequences for both the groups which are the control and test miRNAs. 
 
Relative frequency = Positional frequency/ Total No. of sequences 
 
Using the relative frequencies calculated for each of the nucleotide at all 
positions the graphs were plotted to compare the variations in the pattern 
of position wise nucleotide frequency distribution between the upregulated 
test miRNA and the control miRNA. Then TREND ANALYSIS for each 
of the nucleotides was performed and added to these line graphs to 
compare the trend of nucleotide frequency distribution for each nucleotide 
base in test and control miRNA dataset. 
 
Results and Discussion: 
The upregulated miRNA sequences show a significant increase in the AU 
content. The average AU and GC content of control miRNAs were 
calculated to be 50% each by our analysis. On the other hand the AU and 
GC content of test miRNA sequences were found to be 56% and 44%. We 
observed that there is a significant increase in the AU content in the 
upregulated miRNA sequences (Figure 1). Analysis of the AU and GC 
content in the downregulated miRNA sequences were also done but 
difference was not significant (data not shown). 
 
Trend Analysis: To visualize the trend of frequency distribution for each 
nucleotide base the trend analysis graphs were plotted for control and test 
sequences. For nucleotide “A” the trend analysis showed a concave 
downward curve for both control and test sequences with the trend line of 
test curve lying above the control (Figure 2a) indicating higher 
frequencies of this nucleotide in upregulated sequences. The trend for 
nucleotide “U” showed a concave downward curve for the control 
sequences whereas the test sequences showed almost a linear curve 
(Figure 2b). Nucleotide “G” showed concave downward curves for both 
test and control sequences (Figure 2c). For nucleotide “C” the trend of test 
sequences was similar to that for G, as it showed a concave downward 
curve for both test and control sequences (Figure 2d). The comparative 
trends of normal and test sequences are shown in Figure 2e and 2f 
respectively. These trends noticeably indicate that since the frequency of 
nucleotide “A” and “U” both is higher in the test sequences, hence the 
average AU content becomes high altogether for these sequences. 
 
The AUGC frequency distribution at each of the nucleotide positions was 
analyzed for control and compared with that for the test by plotting line 
graphs from the data calculated from these sequences (See Supplementary 
material) When these graphs were compared for the control and test 
sequences, the test graph were observed to have a considerable variation at 
each position and for each nucleotide, thus indicating role of sequence 
composition in the upregulation of miRNA in cardiac cells. Further control 
of test sequences was subjected to analysis using DNA SCANNER such as 
A-rule, thermodynamic parameters etc. to generate dinucleotide 
distributions of miRNA sequences. 
 
Conclusion: 
The AU richness in miRNA genes involved in cardiac diseases may be of 
importance but requires further studies. AU richness and other parameters 
may play a role in their prediction. This is a preliminary study where we 
hypothesise role of sequence based parameters in identification of 
upregulated miRNA involved in cardiac diseases. 
 
AU-rich elements (AREs) can act as an important paradigm for post-
transcriptional regulation as a control of cytoplasmic mRNA in the 3' 
untranslated region of transcripts encoding oncoproteins, cytokines and 
transcription factors. Many RNA-binding proteins have been shown to 
bind to AREs in vitro. Therefore higher AU content may reflect better 
binding of certain proteins and thus, a stress condition of heart [14]. 
 
Sequence composition as well as sequence based patterns (thermodynamic 
features) plays a role in several biological functions. Sequence 
composition as well as sequence based patterns such as protein induced 
deformability, propeller twist etc. play a role in identification of genomic 
features such as Transcription start sites (TSS), insertion sites 
retrotransposons etc. Therefore it would be important to understand 
genomic neighbourhood of these upregulated miRNA. Further experiments 
are needed to understand the role of high AU content in upregulated 
miRNA. 
 
 
Figure 1: A comparative analysis of the mononucleotide A, U, G & C and dinucleotides G+C & A+U, calculated for the normal and upregulated miRNA
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Figure 2: Positional frequency distribution (a), (b), (c), (d) show the comparison between test (upregulated) and control (normal) miRNAs of nucleotide 
A, U, G and C respectively. The plots also show the trend lines for each of the nucleotide’s positional frequency in case of both test and control datasets. 
(e) and (f) show the trends of all four nucleotides in normal and upregulated miRNAs respectively. The x-axis is the nucleotide position and y-axis is the 
frequency of occurrence of nucleotide.  
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Supplementary materials: 
 
 
Nucleotide frequency distribution of miRNAs: (a) Nucleotide position wise AUGC distribution of all miRNAs. (b) The nucleotide position wise AUGC 
distribution for Upregulated miRNAs. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
